Patient Access
The tech giant and its partners will work to make AI-enabled eyesight-saving care more readily available to clinical systems across both countries.
The newly released PDTs, now RESET and RESET-O, deliver a self-directed, 12-week course of cognitive behavioral therapy that incentivizes patients to conform to treatment.
The New York-based company will use the investment to grow its partnerships and coverage among payers and move into Medicare populations in 2025.
The company helps FQHCs, STD and Ryan White clinics develop, operate and grow in-house pharmacy programs focused on HIV and Hepatitis C patient populations.
The company will use the funds to accelerate its product expansion on a global scale.
SPRY Therapeutics, an AI-enabled physical therapy platform, and Every Cure, an AI-powered biotech organization, also secured funds.
The acquisition allows Resilience Lab to integrate Options MD's medication management and psychotherapy offerings for individuals with severe mental illness.
The aim is to expand Hello Heart's reach across patient populations by utilizing the Amwell platform.
The pair will utilize the data analytics company's services to improve real-time data and predictive analytics capabilities to support VA centers nationwide.
The seed-funding round will be used to expand the company's addiction and support recovery app.